BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld
BioWorld
May 14, 2004
View Archived Issues
Genta Slashes Work Force To Curb Spending, Conserve Cash
Ten days after an FDA panel voted against Genta Inc.'s lead drug candidate, the company laid off nearly half its work force in an effort to conserve cash. (BioWorld Today)
Read More
Dyax, Syntonix Enter Antibody Drug Development Agreement
Read More
Ensemble Discovery Series A Gets $15M For 'Pioneer' Work
Read More
As Investor Interest Grows, Northfield Raising $23.4M
Read More
Other News To Note
Read More